# Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.

> **NCT07229027** · — · RECRUITING · sponsor: **Medialis Ltd.** · enrollment: 500 (estimated)

## Conditions studied

- Overweight (BMI > 25)
- Obesity & Overweight

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07229027
- **Lead sponsor:** Medialis Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2026-07
- **Final completion:** 2026-08
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07229027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07229027, "Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07229027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*